The structure of the microbial population and the pH of the surrounding environment determine whether these metabolic byproducts are beneficial or harmful
The right bundle depends on your daily macro targets
A novel oral formulation of the GLP-1 receptor agonist semaglutide (Rybelsus) was recently approved for the treatment of T2DM
GLP-1 drugs can cause pancreatitis, kidney injury, bowel obstruction, ministry warns In India, GLP-1 drugs can only be prescribed by endocrinologists, internal medicine specialists, and cardiologists
Coverage varies widely from plan to plan
By being informed and proactive, we can navigate the world of supplements together, making choices that enhance our health and well-being.